3rd Quarter - Report

TCH GROUP, LLC for AMGEN USA INC

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare Coverage Reimbursement Issues Implementation of P.L. 111-148, "Patient Protection and Affordable Care Act" (End Stage Renal Disease) Implementation of P.L. 111-152, "Reconciliation Act of 2010" (End Stage Renal Disease; Medicaid Drug Rebate Program)

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.